Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) Stock Price & Growth Analysis

Quote Panel

Updated July 12, 2025

1W -0.09 % 1M 0.66 % 3M -1.39 % 1Y -3.05 %

Key Metrics

Market Cap
21.45B
Shares Outstanding
1.01B
Share in Float
553.23M
Dividende
2.5875

Earning Date
No Data
Price Target
21.29
Average Volume
10.26M
Beta
-0.203

Range
20.36-29.98
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.nhwa-group.com
Sector
Healthcare

Fundamentals

18.20x

P/E Ratio

3.68x

P/S Ratio

2.80x

P/B Ratio

0.0

Debt/Equity

20.2%

Net Margin

$1.2

EPS

How 002262.SZ compares to sector?

P/E Ratio

Fundamentals

Relative Strength

002262.SZ

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$7B

389%

2026-Revenue

$1.48

394%

2026-EPS

$2B

491%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q2.23

+23%

0.32
vs 0.26

Q3.23

+17%

0.34
vs 0.29

Q4.23

N/A

0.15
vs NA

Q1.24

+13%

0.26
vs 0.23

Q2.24

+13%

0.36
vs 0.32

Q3.24

+15%

0.39
vs 0.34

Q4.24

-20%

0.12
vs 0.15

Q1.25

+15%

0.3
vs 0.26

Q2.25

+3%

0.37
vs 0.36

Q3.25

+5%

0.41
vs 0.39

Sales Growth

YoY

Current

Estimates

Q2.23

+21%

1.2B vs 1B

Q3.23

+12%

1.3B vs 1.1B

Q4.23

1.4B vs NA

Q1.24

+14%

1.3B vs 1.2B

Q2.24

+14%

1.4B vs 1.2B

Q3.24

+10%

1.4B vs 1.3B

Q4.24

+14%

1.6B vs 1.4B

Q1.25

+13%

1.5B vs 1.3B

Q2.25

+17%

1.6B vs 1.4B

Q3.25

+19%

1.6B vs 1.4B

Return on Equity

QoQ

Q2.23

+5%

0.05
vs 0.04

Q3.23

+5%

0.05
vs 0.05

Q4.23

+2%

0.02
vs 0.05

Q1.24

+4%

0.04
vs 0.02

Q2.24

+5%

0.05
vs 0.04

Q3.24

+5%

0.05
vs 0.05

Q4.24

+2%

0.02
vs 0.05

Q1.25

+4%

0.04
vs 0.02

Institutionnal Ownership

Company Description

21.29CNY

18.20x

3.68x

2.80x

0.0

20.2%

$1.2

$7B

$1.48

$2B

Earnings Growth

Latest News

Company Description

21.29CNY

18.20x

3.68x

2.80x

0.0

20.2%

$1.2